| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
1
1
5
3
2
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
2 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
U.S. News evaluated 38 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
Performance
The fund has returned 22.94 percent over the past year, 14.72 percent over the past three years, 7.76 percent over the past five years, and 10.63 percent over the past decade.
| Trailing Returns | Updated 05.31.2013 |
|---|---|
| Year to date | 16.2% |
| 1 Year | 22.9% |
| 3 Years (Annualized) | 14.7% |
| 5 Years (Annualized) | 7.8% |
| 10 Years (Annualized) | 10.6% |
Summary
The investment seeks long-term capital appreciation. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can also invest in derivative instruments.
Fees
Fees are Above Average compared to funds in the same category.
Alger Health Sciences Portfolio has an expense ratio of 2.14 percent.
Risk
Risk is Average compared to funds in the same category according to Morningstar.
